The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Cancer epigenetics
Abstract
The field of cancer epigenetics is evolving rapidly on several fronts. Advances in our understanding of chromatin structure, histone modification, transcriptional activity and DNA methylation have resulted in an increasingly integrated view of epigenetics. In response to these insights, epigenetic therapy is expanding to include combinations of histone deacetylase inhibitors and DNA methyltransferase inhibitors. Zebularine, an orally administerable DNA methyltransferase inhibitor, has been a very promising recent addition to our arsenal of potentially useful drugs for epigenetic therapy. Aberrant DNA methylation patterns provide three powerful diagnostic applications as classification markers, sensitive detection markers, and risk assessment markers. Classification studies continue to increase in marker complexity, now incorporating microarrays, high-throughput bisulfite genomic sequencing and mass spectrometry, as the field moves to human epigenome projects. Sensitive detection technology has expanded from primarily blood-based cancer detection to include applications on a wide diversity of sample sources and is now also making inroads as a molecular risk assessment tool.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Induction of DNA methylation and gene silencing by short interfering RNAs in human cells
Kawasaki, H., & Taira, K. (2004) · Nature · doi:10.1038/nature02889 · Cited by 367
RetractedRoman-Gomez, J., Jimenez-Velasco, A., Castillejo, J. A., Agirre, X., Barrios, M., Navarro, G., Molina, F. J., Calasanz, M. J., Prosper, F., Heiniger, A., et al. (2004) · Blood · doi:10.1182/blood-2004-03-0954 · Cited by 208
RetractedGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationInactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Multiclass cancer diagnosis using tumor gene expression signatures
Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.-H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211566398 · Cited by 2,023
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
The power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
Self-citationDNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,538
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499 · cited 1×
“Increased lymphomagenesis in Dnmt1 hypomorphic mice was subsequently confirmed in mice without an Mlh1 mutation (178).”
BackgroundEpigenetic inheritance at the agouti locus in the mouse
Morgan, H. D., Sutherland, H. G. E., Martin, D. I. K., & Whitelaw, E. (1999) · Nature Genetics · doi:10.1038/15490 · Cited by 1,476 · cited 1×
“Such transgenerational epigenetic inheritance has been well documented to occur in mice (169,170) (Ruden, this issue).”
BackgroundMethyLight: a high-throughput assay to measure DNA methylation
Eads, C. A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.8.e32 · Cited by 1,424
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
Esteller, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205600 · Cited by 1,233
Genetic analysis of genome-wide variation in human gene expression
Morley, M., Molony, C. M., Weber, T. M., Devlin, J. L., Ewens, K. G., Spielman, R. S., & Cheung, V. G. (2004) · Nature · doi:10.1038/nature02797 · Cited by 1,207
Felsenfeld, G., & Groudine, M. (2003) · Nature · doi:10.1038/nature01411 · Cited by 1,150
CpG island methylator phenotype in cancer
Issa, J.-P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1507 · Cited by 1,098
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., et al. (2002) · Nature · doi:10.1038/416552a · Cited by 1,039
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 954
Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells
Morris, K. V., Chan, S. W.-L., Jacobsen, S. E., & Looney, D. J. (2004) · Science · doi:10.1126/science.1101372 · Cited by 925
Proteomic applications for the early detection of cancer
Wulfkuhle, J. D., Liotta, L. A., & Petricoin, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1043 · Cited by 907
Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M. P., Herman, J. G., & Baylin, S. B. (2002) · Nature Genetics · doi:10.1038/ng892 · Cited by 857
Growing Y-junction carbon nanotubes
Li, J., Papadopoulos, C., & Xu, J. (1999) · Nature · doi:10.1038/46214 · Cited by 818
Issa, J.-P. J., Garcia-Manero, G., Giles, F. J., Mannari, R., Thomas, D., Faderl, S., Bayar, E., Lyons, J., Rosenfeld, C. S., Cortes, J., et al. (2004) · Blood · doi:10.1182/blood-2003-03-0687 · Cited by 809
Hegi, M. E., Diserens, A.-C., Godard, S., Dietrich, P.-Y., Regli, L., Ostermann, S., Otten, P., Van Melle, G., de Tribolet, N., & Stupp, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0384 · Cited by 783
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome
Hansen, R. S., Wijmenga, C., Luo, P., Stanek, A. M., Canfield, T. K., Weemaes, C. M. R., & Gartler, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14412 · Cited by 735
Suppression of intestinal neoplasia by DNA hypomethylation
Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Edward Jung, W., Li, E., Weinberg, R. A., & Jaenisch, R. (1995) · Cell · doi:10.1016/0092-8674(95)90329-1 · Cited by 710
Self-citationHistone sumoylation is associated with transcriptional repression
Shiio, Y., & Eisenman, R. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735528100 · Cited by 702
Jüttermann, R., Li, E., & Jaenisch, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11797 · Cited by 678
Veigl, M. L., Kasturi, L., Olechnowicz, J., Ma, A., Lutterbaugh, J. D., Periyasamy, S., Li, G.-M., Drummond, J., Modrich, P. L., Sedwick, W. D., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8698 · Cited by 648
Rakyan, V. K., Chong, S., Champ, M. E., Cuthbert, P. C., Morgan, H. D., Luu, K. V. K., & Whitelaw, E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436776100 · Cited by 641
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
Robert, M.-F., Morin, S., Beaulieu, N., Gauthier, F., Chute, I. C., Barsalou, A., & MacLeod, A. R. (2003) · Nature Genetics · doi:10.1038/ng1068 · Cited by 614
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
Nebbioso, A., Clarke, N., Voltz, E., Germain, E., Ambrosino, C., Bontempo, P., Alvarez, R., Schiavone, E. M., Ferrara, F., Bresciani, F., et al. (2005) · Nature Medicine · doi:10.1038/nm1161 · Cited by 610
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., & Selker, E. U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.399 · Cited by 535
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg315 · Cited by 523 · cited 1×
“Depudecin Epoxide (214) FK228 Depsipeptide, FR901228 Phase I/II (215) MS-275 Benzamidine Phase I (216) LAQ824 Phase I (217) Oxamflatin (218) MGCD0103 Phase I (219) PXD101 Phase I (220) Pyroxamide Phase I (221) RNAi (222) Suberic Bishydroxamic Acid SBHA (223) Suberoylanilide Hydroxamic Acid SAHA Phase I/II (224) Tricho…”
BackgroundChromatin Architecture of the Human Genome
Gilbert, N., Boyle, S., Fiegler, H., Woodfine, K., Carter, N. P., & Bickmore, W. A. (2004) · Cell · doi:10.1016/j.cell.2004.08.011 · Cited by 501
Esteller, M., Levine, R., Baylin, S. B., Ellenson, L. H., & Herman, J. G. (1998) · Oncogene · doi:10.1038/sj.onc.1202178 · Cited by 493
Lund, A. H., & van Lohuizen, M. (2004) · Genes & Development · doi:10.1101/gad.1232504 · Cited by 489
Liang, G., Lin, J. C. Y., Wei, V., Yoo, C., Cheng, J. C., Nguyen, C. T., Weisenberger, D. J., Egger, G., Takai, D., Gonzales, F. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401866101 · Cited by 484
Germline epimutation of MLH1 in individuals with multiple cancers
Suter, C. M., Martin, D. I. K., & Ward, R. L. (2004) · Nature Genetics · doi:10.1038/ng1342 · Cited by 475
Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
Toyota, M., Ohe-Toyota, M., Ahuja, N., & Issa, J.-P. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.710 · Cited by 473
Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells
Lorincz, M. C., Dickerson, D. R., Schmitt, M., & Groudine, M. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb840 · Cited by 461
Weinmann, A. S., Yan, P. S., Oberley, M. J., Huang, T. H.-M., & Farnham, P. J. (2002) · Genes & Development · doi:10.1101/gad.943102 · Cited by 443
Role for DNA methylation in the control of cell type–specific maspin expression
Futscher, B. W., Oshiro, M. M., Wozniak, R. J., Holtan, N., Hanigan, C. L., Duan, H., & Domann, F. E. (2002) · Nature Genetics · doi:10.1038/ng886 · Cited by 442
Kornblith, A. B., Herndon, J. E., Silverman, L. R., Demakos, E. P., Odchimar-Reissig, R., Holland, J. F., Powell, B. L., DeCastro, C., Ellerton, J., Larson, R. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.044 · Cited by 419
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
Bachman, K. E., Park, B. H., Rhee, I., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., & Vogelstein, B. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00234-9 · Cited by 418
Graff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B., & Herman, J. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2727 · Cited by 393
Boggs, B. A., Cheung, P., Heard, E., Spector, D. L., Chinault, A. C., & Allis, C. D. (2002) · Nature Genetics · doi:10.1038/ng787 · Cited by 378
Rakyan, V. K., Hildmann, T., Novik, K. L., Lewin, J., Tost, J., Cox, A. V., Andrews, T. D., Howe, K. L., Otto, T., Olek, A., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020405 · Cited by 359
Epigenomics: beyond CpG islands
Fazzari, M. J., & Greally, J. M. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1349 · Cited by 352
Critical Role of Histone Methylation in Tumor Suppressor Gene Silencing in Colorectal Cancer
Kondo, Y., Shen, L., & Issa, J.-P. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.206-215.2003 · Cited by 346
Widschwendter, M., Siegmund, K. D., Müller, H. M., Fiegl, H., Marth, C., Müller-Holzner, E., Jones, P. A., & Laird, P. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3852 · Cited by 324
Self-citationPreferential response of cancer cells to zebularine
Cheng, J. C., Yoo, C. B., Weisenberger, D. J., Chuang, J., Wozniak, C., Liang, G., Marquez, V. E., Greer, S., Orntoft, T. F., Thykjaer, T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.023 · Cited by 319
Jeronimo, C., Usadel, H., Henrique, R., Oliveira, J., Lopes, C., Nelson, W. G., & Sidransky, D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1747 · Cited by 306
Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation
Yu, W., Ginjala, V., Pant, V., Chernukhin, I., Whitehead, J., Docquier, F., Farrar, D., Tavoosidana, G., Mukhopadhyay, R., Kanduri, C., et al. (2004) · Nature Genetics · doi:10.1038/ng1426 · Cited by 298
Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9
Mutskov, V., & Felsenfeld, G. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600013 · Cited by 296
Vertino, P. M., Yen, R.-W. C., Gao, J., & Baylin, S. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4555 · Cited by 288
Tumour class prediction and discovery by microarray-based DNA methylation analysis
Adorjan, P. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.5.e21 · Cited by 285
Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability
Cui, H., Horon, I. L., Ohlsson, R., Hamilton, S. R., & Feinberg, A. P. (1998) · Nature Medicine · doi:10.1038/3260 · Cited by 284
Methylation changes in faecal DNA: a marker for colorectal cancer screening?
Müller, H. M., Oberwalder, M., Fiegl, H., Morandell, M., Goebel, G., Zitt, M., Mühlthaler, M., Öfner, D., Margreiter, R., & Widschwendter, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16002-9 · Cited by 283
de Caceres, I. I., Battagli, C., Esteller, M., Herman, J. G., Dulaimi, E., Edelson, M. I., Bergman, C., Ehya, H., Eisenberg, B. L., & Cairns, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1529 · Cited by 282
Altered methylation patterns in cancer cell genomes: Cause or consequence?
Baylin, S., & Bestor, T. H. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00061-2 · Cited by 280
Predicting aberrant CpG island methylation
Feltus, F. A., Lee, E. K., Costello, J. F., Plass, C., & Vertino, P. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2037852100 · Cited by 278
Paz, M. F., Yaya-Tur, R., Rojas-Marcos, I., Reynes, G., Pollan, M., Aguirre-Cruz, L., García-Lopez, J. L., Piquer, J., Safont, M.-J., Balaña, C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0392 · Cited by 261
Freiman, R. N., & Tjian, R. (2003) · Cell · doi:10.1016/s0092-8674(02)01278-3 · Cited by 259
Methylation of Adjacent CpG Sites Affects Sp1/Sp3 Binding and Activity in the p21Cip1 Promoter
Zhu, W.-G., Srinivasan, K., Dai, Z., Duan, W., Druhan, L. J., Ding, H., Yee, L., Villalona-Calero, M. A., Plass, C., & Otterson, G. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4056-4065.2003 · Cited by 257
Vanhaecke, T., Papeleu, P., Elaut, G., & Rogiers, V. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365099 · Cited by 255
Stirzaker, C., Song, J. Z., Davidson, B., & Clark, S. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3690 · Cited by 240
Kang, G. H., Lee, H. J., Hwang, K. S., Lee, S., Kim, J.-H., & Kim, J.-S. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63511-0 · Cited by 239
K-ras and p16 Aberrations Confer Poor Prognosis in Human Colorectal Cancer
Esteller, M., González, S., Risques, R. A., Marcuello, E., Mangues, R., Germà, J. R., Herman, J. G., Capellà, G., & Peinado, M. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.299 · Cited by 234
Histone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells
Takai, N., Desmond, J. C., Kumagai, T., Gui, D., Said, J. W., Whittaker, S., Miyakawa, I., & Koeffler, H. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0100 · Cited by 233
Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase
Kim, Y. B., Lee, K.-H., Sugita, K., Yoshida, M., & Horinouchi, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202564 · Cited by 232
Kantarjian, H. M., O'Brien, S., Cortes, J., Giles, F. J., Faderl, S., Issa, J., Garcia‐Manero, G., Rios, M. B., Shan, J., Andreeff, M., et al. (2003) · Cancer · doi:10.1002/cncr.11543 · Cited by 227
Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells
Cheng, J. C., Weisenberger, D. J., Gonzales, F. A., Liang, G., Xu, G.-L., Hu, Y.-G., Marquez, V. E., & Jones, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1270-1278.2004 · Cited by 222
Kwon, S. H., Ahn, S. H., Kim, Y. K., Bae, G.-U., Yoon, J. W., Hong, S., Lee, H. Y., Lee, Y.-W., Lee, H.-W., & Han, J.-W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106699200 · Cited by 215
Hoque, M. O., Begum, S., Topaloglu, O., Jeronimo, C., Mambo, E., Westra, W. H., Califano, J. A., & Sidransky, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0799 · Cited by 213
Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase
Jackson-Grusby, L., Laird, P. W., Magge, S. N., Moeller, B. J., & Jaenisch, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4681 · Cited by 208
Self-citationIntegrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors
Zardo, G., Tiirikainen, M. I., Hong, C., Misra, A., Feuerstein, B. G., Volik, S., Collins, C. C., Lamborn, K. R., Bollen, A., Pinkel, D., et al. (2002) · Nature Genetics · doi:10.1038/ng1007 · Cited by 203
Kwon, H. J., Owa, T., Hassig, C. A., Shimada, J., & Schreiber, S. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3356 · Cited by 197
Karpf, A. R., Peterson, P. W., Rawlins, J. T., Dalley, B. K., Yang, Q., Albertsen, H., & Jones, D. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14007 · Cited by 196
Zhang, X. D., Gillespie, S. K., Borrow, J. M., & Hersey, P. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.425.3.4 · Cited by 190
Genetics supersedes epigenetics in colon cancer phenotype
Yamashita, K., Dai, T., Dai, Y., Yamamoto, F., & Perucho, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00190-9 · Cited by 188
Leu, Y.-W., Yan, P. S., Fan, M., Jin, V. X., Liu, J. C., Curran, E. M., Welshons, W. V., Wei, S. H., Davuluri, R. V., Plass, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2045 · Cited by 188
DNA methylation and cancer therapy: new developments and expectations
Esteller, M. (2005) · Current Opinion in Oncology · doi:10.1097/01.cco.0000147383.04709.10 · Cited by 183
Kudo, Y., Kitajima, S., Ogawa, I., Hiraoka, M., Sargolzaei, S., Keikhaee, M. R., Sato, S., Miyauchi, M., & Takata, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0372 · Cited by 182
Gius, D., Cui, H., Bradbury, C. M., Cook, J., Smart, D. K., Zhao, S., Young, L., Brandenburg, S. A., Hu, Y., Bisht, K. S., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.029 · Cited by 181
Mutskov, V. J., Farrell, C. M., Wade, P. A., Wolffe, A. P., & Felsenfeld, G. (2002) · Genes & Development · doi:10.1101/gad.988502 · Cited by 178
Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells
Song, J. Z., Stirzaker, C., Harrison, J., Melki, J. R., & Clark, S. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205153 · Cited by 177
Deficiency of Mbd2 suppresses intestinal tumorigenesis
Sansom, O. J., Berger, J., Bishop, S. M., Hendrich, B., Bird, A., & Clarke, A. R. (2003) · Nature Genetics · doi:10.1038/ng1155 · Cited by 176
Promoter Hypermethylation of Resected Bronchial Margins
Guo, M., House, M. G., Hooker, C. M., Han, Y. K., Heath, E., Gabrielson, E. W., Yang, S. C., Baylin, S. B., Herman, J. G., & Brock, M. V. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0763 · Cited by 173
Detection of Breast Cancer in Nipple Aspirate Fluid by CpG Island Hypermethylation
Krassenstein, R., Sauter, E., Dulaimi, E., Battagli, C., Ehya, H., Klein-Szanto, A., & Cairns, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0410-3 · Cited by 171
Chromatin Insulators and Boundaries: Effects on Transcription and Nuclear Organization
Gerasimova, T. I., & Corces, V. G. (2001) · Annual Review of Genetics · doi:10.1146/annurev.genet.35.102401.090349 · Cited by 161
Reid, T., Valone, F., Lipera, W., Irwin, D., Paroly, W., Natale, R., Sreedharan, S., Keer, H., Lum, B., Scappaticci, F., et al. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.03.002 · Cited by 159
Epigenetic silencing of multiple interferon pathway genes after cellular immortalization
Kulaeva, O. I., Drăghici, S., Tang, L., Kraniak, J. M., Land, S. J., & Tainsky, M. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206594 · Cited by 154
Lsh, an epigenetic guardian of repetitive elements
Huang, J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh821 · Cited by 148
Feature selection for DNA methylation based cancer classification
Model, F., Adorján, P., Olek, A., & Piepenbrock, C. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.suppl_1.s157 · Cited by 147
Mehrotra, J., Vali, M., McVeigh, M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0118 · Cited by 143
Integrated global profiling of cancer
Hanash, S. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1414 · Cited by 137
Lucas, D. M., Davis, M. E., Parthun, M. R., Mone, A. P., Kitada, S., Cunningham, K. D., Flax, E. L., Wickham, J., Reed, J. C., Byrd, J. C., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403388 · Cited by 136
Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells
Guo, G., Wang, W., & Bradley, A. (2004) · Nature · doi:10.1038/nature02653 · Cited by 135
Clustering of Gene Hypermethylation Associated With Clinical Risk Groups in Neuroblastoma
Alaminos, M., Dávalos, V., Cheung, N. V., Gerald, W. L., & Esteller, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh224 · Cited by 129
Histone deacetylase inhibitors specifically kill nonproliferating tumour cells
Burgess, A., Ruefli, A. A., Beamish, H., Warrener, R., Saunders, N. A., Johnstone, R. W., & Gabrielli, B. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207893 · Cited by 128
Paz, M. F. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg226 · Cited by 127
Lorincz, M. C., Schübeler, D., Hutchinson, S. R., Dickerson, D. R., & Groudine, M. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7572-7580.2002 · Cited by 125
Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas
Lee, J.-H., Park, S. J., Abraham, S. C., Seo, J.-S., Nam, J., Choi, C., Juhng, S., Rashid, A., Hamilton, S. R., & Wu, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207588 · Cited by 124
The Epigenome as a Target for Cancer Chemoprevention
Kopelovich, L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dig109 · Cited by 124
Bovenzi, V., & Momparler, R. L. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100294 · Cited by 118
Miyakura, Y., Sugano, K., Akasu, T., Yoshida, T., Maekawa, M., Saitoh, S., Sasaki, H., Nomizu, T., Konishi, F., Fujita, S., et al. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)00314-8 · Cited by 114
Honorio, S., Agathanggelou, A., Schuermann, M., Pankow, W., Viacava, P., Maher, E. R., & Latif, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206057 · Cited by 111
Takahashi, T., Shivapurkar, N., Riquelme, E. M., Shigematsu, H., Reddy, J., Suzuki, M., Miyajima, K., Zhou, X. C., Bekele, B. N., Gazdar, A. F., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0579 · Cited by 110
Diagnosing Pancreatic Cancer Using Methylation Specific PCR Analysis
Fukushima, N., Walter, K., Ueki, T., Sato, N., Matsubayashi, H., Cameron, J. L., Hruban, R. H., Canto, M. I., Yeo, C. J., & Goggins, M. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.183 · Cited by 106
DNA Methyltransferase Deficiency Modifies Cancer Susceptibility in Mice Lacking DNA Mismatch Repair
Trinh, B. N., Long, T. I., Nickel, A. E., Shibata, D. K., & Laird, P. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2906-2917.2002 · Cited by 102
Self-citationAnalysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma
Khan, S., Maududi, T., Barton, K., Ayers, J., & Alkan, S. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04882.x · Cited by 100
Pompéia, C., Hodge, D. R., Plass, C., Wu, Y.-Z., Márquez, V. E., Kelley, J. A., & Farrar, W. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3970 · Cited by 97
Lsh, a modulator of CpG methylation, is crucial for normal histone methylation
Yan, Q., Huang, J., Fan, T., Zhu, H., & Muegge, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg493 · Cited by 96
Trans allele methylation and paramutation-like effects in mice
Herman, H., Lu, M., Anggraini, M., Sikora, A., Chang, Y., Yoon, B. J., & Soloway, P. D. (2003) · Nature Genetics · doi:10.1038/ng1162 · Cited by 95
Sathyanarayana, U. G., Maruyama, R., Padar, A., Suzuki, M., Bondaruk, J. E., Sagalowsky, A. I., Minna, J. D., Frenkel, E. P., Grossman, H. B., Czerniak, B. A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0701 · Cited by 93
Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients
Yuasa, Y., Nagasaki, H., Akiyama, Y., Sakai, H., Nakajima, T., Ohkura, Y., Takizawa, T., Koike, M., Tani, M., Iwai, T., et al. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh304 · Cited by 92
Christmann, M., Pick, M., Lage, H., Schadendorf, D., & Kaina, B. (2001) · International Journal of Cancer · Cited by 89
p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer
Gerdes, B., Ramaswamy, A., Ziegler, A., Lang, S. A., Kersting, M., Baumann, R., Wild, A., Moll, R., Rothmund, Μ., & Bartsch, D. K. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00007 · Cited by 89
Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells
Kim, M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh912 · Cited by 89
The Discovery of NVP-LAQ824: From Concept to Clinic
Remiszewski, S. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456675 · Cited by 88
Genome-wide demethylation destabilizes CTG·CAG trinucleotide repeats in mammalian cells
Gorbunova, V. A., Seluanov, A., Mittelman, D., & Wilson, J. H. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh317 · Cited by 86
From genomics to epigenomics: a loftier view of life
Beck, S., Olek, A., & Walter, J. (1999) · Nature Biotechnology · doi:10.1038/70651 · Cited by 82
Nouzová, M., Holtan, N., Oshiro, M. M., Isett, R. B., Muñoz-Rodríguez, J. L., List, A. F., Narro, M. L., Miller, S. J., Merchant, N. C., & Futscher, B. W. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072488 · Cited by 82
Mummaneni, P., Yates, P. A., Simpson, J. F., Rose, J., & Turker, M. S. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.22.5163 · Cited by 81
Widschwendter, A., Gattringer, C., Ivarsson, L., Fiegl, H., Schneitter, A., Ramoni, A., Müller, H. M., Wiedemair, A., Jerabek-Klestil, S., Müller‐Holzner, E., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0143 · Cited by 81
Sun, Y. L., Deng, D., You, W., Bai, H., Zhang, L., Zhou, J., Shen, L., Ma, J., Xie, Y., & Li, J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0622 · Cited by 75
Ordway, J. M., Williams, K., & Curran, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207483 · Cited by 72
The relationship between aberrant methylation and survival in non-small-cell lung cancers
Toyooka, S., Suzuki, M., Maruyama, R., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602013 · Cited by 71
Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis
Gonzalgo, M. L., Nakayama, M., Lee, S. M., Marzo, A. M. D., & Nelson, W. G. (2004) · Urology · doi:10.1016/j.urology.2003.08.039 · Cited by 71
Mori, Y., Yin, J., Sato, F., Sterian, A., Simms, L. A., Selaru, F. M., Schulmann, K., Xu, Y. H., Olaru, A., Wang, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3508 · Cited by 70
A comparison of cluster analysis methods using DNA methylation data
Siegmund, K. D., Laird, P. W., & Laird‐Offringa, I. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth176 · Cited by 69
Self-citationChan, M. F., van Amerongen, R., Nijjar, T., Cuppen, E. P. J. G., Jones, P. A., & Laird, P. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7587-7600.2001 · Cited by 69
Self-citationPericonceptional folate and neural tube defect
Rush, D. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.2.511s · Cited by 66
Lamy, A., Sesboüé, R., Bourguignon, J., Dautréaux, B., Métayer, J., Frébourg, T., & Thiberville, L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10474 · Cited by 66
Oberley, M. J., & Farnham, P. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)71043-x · Cited by 60
Zingg, J.-M. A., Shen, J. C., Yang, A. S., Rapoport, H., & Jones, P. A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.16.3267 · Cited by 51
DNA methyltransferase Dnmt1 and mismatch repair
Wang, K.-Y., & Shen, C.-K. J. (2004) · Oncogene · doi:10.1038/sj.onc.1208111 · Cited by 50
Analysis of Methylated Genes in Peritoneal Fluids of Ovarian Cancer Patients: A New Prognostic Tool
Müller, H. M., Millinger, S., Fiegl, H., Goebel, G., Ivarsson, L., Widschwendter, A., Müller‐Holzner, E., Marth, C., & Widschwendter, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.034090 · Cited by 36
DNA methylation and gastrointestinal malignancies: functional consequences and clinical implications
Toyota, M., Itoh, F., & Imai, K. (2000) · Journal of Gastroenterology · doi:10.1007/s005350070030 · Cited by 26
DNA Methylation Patterns in Cancer: Novel Prognostic Indicators?
hwald, M. C. F. (2003) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200303040-00003 · Cited by 22
Purchase of Aton spotlights HDAC inhibitors
Garber, K. (2004) · Nature Biotechnology · doi:10.1038/nbt0404-364 · Cited by 14
Kang, S.-H. L., Kiefer, C. M., & Yang, T. P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4150-4161.2003 · Cited by 12
On the use of DNA methylation inhibitors and the reversal of transcriptional silencing
El‐Osta, A. (2003) · Blood · doi:10.1182/blood-2002-10-3003 · Cited by 9
Watanabe, T., Yoshimura, A., Mishima, Y., Endo, Y., Shiroishi, T., Koide, T., Sasaki, H., Asakura, H., & Kominami, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3029 · Cited by 6
Cited by
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Self-citationEpigenetics and the biological definition of gene×environment interactions
Meaney, M. J. (2010) · Child Development · doi:10.1111/j.1467-8624.2009.01381.x · Cited by 1,239
Exploring the Genomes of Cancer Cells: Progress and Promise
Stratton, M. R. (2011) · Science · doi:10.1126/science.1204040 · Cited by 693
Is folic acid good for everyone?
Smith, A. D., Kim, Y.-I., & Refsum, H. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.517 · Cited by 612
Epigenetic Mechanisms and the Mismatch Concept of the Developmental Origins of Health and Disease
Godfrey, K. M., Lillycrop, K. A., Burdge, G. C., Gluckman, P. D., & Hanson, M. A. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e318045bedb · Cited by 595
Metadata
- Authors
- Laird, P. W.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-04-15
- Volume
- 14
- Issue
- suppl_1
- Pages
- R65-R76
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W4211231408
- Cited by
- 398
- References
- 158
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.